Where is Accelmed's headquarters located?

Accelmed's headquarters is located in Miami (United States).

How big is Accelmed's investment team?

Accelmed has a team of 12, including 7 partners.

How many companies has Accelmed invested in?

Accelmed has invested in 33 companies, including NeuroPace & Click Therapeutics.

Which companies has Accelmed invested in lately?

Corvia Medical & Acclaro Medical are the latest investments by Accelmed.

Accelmed - 2026 Investor Profile, Portfolio, Team & Exits

Most viewed in 2019

Accelmed is a private equity firm founded in 2009. It is primarily based in Miami, United States. As of Aug 2026, Accelmed has a portfolio of 33 companies, comprising 33 funding rounds and 2 acquisitions. The firm primarily invests in companies based in United States and Israel. Its portfolio is spread across a wide range of sectors from Life Sciences to HealthTech. Its latest investment was a $***** Series D round in Corvia Medical on Jun 12, 2025 which also saw participation from Third Rock Ventures, General Catalyst and other investors.

Overall Accelmed portfolio has seen 3 IPOs and 15 acquisitions, namely NeuroPace, Varian Medical Systems and Endospan. A lot of funds co-invest with Accelmed, with names like Revelation Partners sharing a substantial percentage of its portfolio.

Accelmed has a team of 12 people, including 7 partners.

Key Metrics

Founded Year

2009

Location

Miami, United States

Portfolio Companies

NeuroPace, Click Therapeutics & 31 more

Portfolio Sectors

Life Sciences, HealthTech

Portfolio Locations

United States, Israel

Acquisition Deals

TearLab, Keystone Dental

Investment Deals

NeuroPace, Click Therapeutics & 31 more

View Accelmed's full profile

Accelmed has a portfolio of 33 companies. They have invested in a total of 33 companies. Their most recent investment was in Corvia Medical (Series D round) on Jun 12, 2025. Here are the most recent investments by Accelmed:

Date	Company	Round	Amount	Co-Investors
Jun 12, 2025	Corvia Medical	Series D	4614	Third Rock Ventures ... and 2 others
May 30, 2025	Acclaro Medical	Series B	4561	3E Bioventures Capital
May 29, 2025	UltraClear	Series B	2787	3E Bioventures Capital
Dec 23, 2024	GammaTile	Series D	5158	Evidity Health Capital ... and 3 others

View all investments by Accelmed

Accelmed has acquired 2 companies. Their most recent acquisition was of TearLab on May 11, 2020. Here are the most recent acquisitions by Accelmed:

Acquisition Date	Company	Short Description	Total Funding	Founded Year
May 11, 2020	TearLab	Developer of diagnostic tests for detecting hyperosmolarity	-	2003
Jun 04, 2018	Keystone Dental	Dental solutions provider: implants, biomaterials, prosthetics, instruments, and planning software	$86.2M	2006

Here is the portfolio snapshot of Accelmed:

Investments by Year

The maximum number of investments were made in 2025

Acquisitions by Year

The maximum number of acquisitions were made in 2020

Portfolio by Location

Companies are primarily in United States and Israel

Portfolio by Sector

Companies are primarily in Life Sciences

Accelmed has a team of 12 members including 7 Partners, 1 Venture Partner and 2 Principals located in Israel and United States. Accelmed's team sits on the board of 2 companies.

Here is a list of top team members in Accelmed:

Name	Designation	Location	Board Memberships	Contact Details
Uri Geiger	Partner	Israel	Click Therapeutics and Corvia Medical	1 Email
Irit Yaniv	Partner	Israel	-	1 Email
Mori Arkin	Partner	Israel	-	-
Stephen Rubin	Partner	New York City	-	-
Michal Fisher	Partner	Israel	-	-
Guy Ohad	Partner	-	-	-
Susan Alpert	Partner	New York Mills	-	-
Daniel Cohen	Venture Partner	Israel	-	1 Email
Maria Forero	Principal	Miami	Click Therapeutics	1 Email
Camilo Rico	Principal	Philadelphia	-	1 Email